Which element is required in FDA labeling for in vitro diagnostic products?

Which element is required in FDA labeling for in vitro diagnostic products?

• A. Market segment
• B. Product's categorization
• C. Intended use
• D. Classification

Answer: (C)

Intended use is the essential element that must appear on FDA labeling for in vitro diagnostic products. It clearly states what the test is designed to detect or measure, the patient population it's intended for, the specimen types it accepts, and the clinical context in which the test should be used. This specificity prevents misapplication and ensures clinicians and labs interpret results within the approved scope. It also anchors the performance data and any limitations to a defined purpose, so users know what the test can reliably tell them. The other items aren’t labeling requirements in the same way. Market segment describes who the product is marketed to, not how the product is used. Product categorization and classification are regulatory designations used to determine the approval pathway and ongoing compliance, not statements about how the product should be used.

Intended use is the essential element that must appear on FDA labeling for in vitro diagnostic products. It clearly states what the test is designed to detect or measure, the patient population it's intended for, the specimen types it accepts, and the clinical context in which the test should be used. This specificity prevents misapplication and ensures clinicians and labs interpret results within the approved scope. It also anchors the performance data and any limitations to a defined purpose, so users know what the test can reliably tell them.

The other items aren’t labeling requirements in the same way. Market segment describes who the product is marketed to, not how the product is used. Product categorization and classification are regulatory designations used to determine the approval pathway and ongoing compliance, not statements about how the product should be used.